SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon informs about board meeting

03 Jan 2022 Evaluate
Biocon has informed that the meeting the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, January 20, 2022, to approve and take on record the un-audited standalone and consolidated financial results for the quarter and nine months ended December 31, 2021, amongst other routine matters. The trading window for dealing in securities of the Company for all insiders, as defined under the Code of Conduct for Prevention of Insider Trading ('the Code') of the Company, has been closed from January 1, 2022 to January 22, 2022 in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

358.20 7.65 (2.18%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×